Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 29, 2019

SELL
$10.88 - $17.6 $464,032 - $750,640
-42,650 Closed
0 $0
Q1 2019

Apr 23, 2019

SELL
$15.51 - $17.61 $9,306 - $10,566
-600 Reduced 1.39%
42,650 $751,000
Q3 2018

Oct 29, 2018

SELL
$14.85 - $16.35 $11,137 - $12,262
-750 Reduced 1.7%
43,250 $644,000
Q2 2018

Jul 26, 2018

SELL
$13.8 - $16.8 $96,600 - $117,600
-7,000 Reduced 13.73%
44,000 $700,000
Q4 2017

Jan 31, 2018

SELL
$13.55 - $15.8 $10,162 - $11,850
-750 Reduced 1.45%
51,000 $714,000
Q3 2017

Oct 20, 2017

BUY
$13.45 - $14.35 $696,037 - $742,612
51,750
51,750 $740,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Le Jeune Puetz Investment Counsel LLC Portfolio

Follow Le Jeune Puetz Investment Counsel LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Le Jeune Puetz Investment Counsel LLC, based on Form 13F filings with the SEC.

News

Stay updated on Le Jeune Puetz Investment Counsel LLC with notifications on news.